Experimental evidence and case-control studies suggest that dihydropyridine calcium channel blockers (DiCCBs) may protect against Parkinson’s disease. The authors conducted a historical cohort study in Denmark to investigate the association …
Xuchang Hengsheng Pharmaceutical Co., Ltd.
Manidipine Hydrochloride main manufacturer in the world